Evidence map›Paper›PMID 38106616›Full record

ArticlePatterns (New York, N.Y.)2023

Using machine learning probabilities to identify effects of COVID-19.

Vijendra Ramlall, Undina Gisladottir, Jenna Kefeli, Yutaro Tanaka, Benjamin May, Nicholas Tatonetti

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vijendra RamlallDepartment of Biomedical Informatics, Columbia University, Columbia University Irving Medical Center, New York, NY 10032, USA.
Undina GisladottirDepartment of Biomedical Informatics, Columbia University, Columbia University Irving Medical Center, New York, NY 10032, USA.
Jenna KefeliDepartment of Systems Biology, Columbia University, Columbia University Irving Medical Center, New York, NY 10032, USA.
Yutaro TanakaDepartment of Biomedical Informatics, Columbia University, Columbia University Irving Medical Center, New York, NY 10032, USA.
Benjamin MayHerbert Irving Comprehensive Cancer Center, New York Presbyterian/Columbia University Irving Medical Center, New York, NY 10032, USA.
Nicholas TatonettiDepartment of Biomedical Informatics, Columbia University, Columbia University Irving Medical Center, New York, NY 10032, USA.

Funding

Training in Biomedical Informatics at Columbia UniversityT15LM007079 · NLM · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI NOEMIE ELHADAD, GEORGE M HRIPCSAK · 1992 to 2026
$28.9M
Precision Pharmacology and Pharmacovigilance: Leveraging AI to address drug safety knowledge gapsR35GM131905 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Nicholas P Tatonetti · 2019 to 2026
$3.3M
NIGMS NIH HHS R35 GM131905NLM NIH HHS T15 LM007079
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has had extensive economic, social, and public health impacts in the United States and around the world. To date, there have been more than 600 million reported infections worldwide with more than 6 million reported deaths. Retrospective analysis, which identified comorbidities, risk factors, and treatments, has underpinned the response. As the situation transitions to an endemic, retrospective analyses using electronic health records will be important to identify the long-term effects of COVID-19. However, these analyses can be complicated by incomplete records, which makes it difficult to differentiate visits where the patient had COVID-19. To address this issue, we trained a random Forest classifier to assign a probability of a patient having been diagnosed with COVID-19 during each visit. Using these probabilities, we found that higher COVID-19 probabilities were associated with a future diagnosis of myocardial infarction, urinary tract infection, acute renal failure, and type 2 diabetes.

Indexed as

algorithm developmentclinical informaticsCOVID-19 effectsmachine learningsurvival analysis

Identifiers

PMID38106616
PMCPMC10724367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.